Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$13.42 - $25.18 $1.96 Million - $3.68 Million
-146,142 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$19.28 - $24.59 $462,720 - $590,160
-24,000 Reduced 14.11%
146,142 $3.27 Million
Q4 2020

Feb 16, 2021

BUY
$15.1 - $26.44 $2.5 Million - $4.37 Million
165,346 Added 3447.58%
170,142 $3.78 Million
Q3 2020

Nov 16, 2020

BUY
$13.39 - $17.48 $64,218 - $83,834
4,796 New
4,796 $71,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $802M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.